NCT04634825 · Interventional trial
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer
Overall registry status Terminated
Phase 2
Conditions Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma
Delaware Valley sites
- University of Pennsylvania - Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory